Why has the epidemiology of RSV changed during the COVID-19 pandemic?

Why has the epidemiology of RSV changed during the COVID-19 pandemic?

Summary: The coronavirus disease 2019 (COVID-19) pandemic has drastically perturbed the epidemiology of Respiratory Syncytial Virus (RSV) respiratory tract infections in children. The reasons for this are not clear. In this article, we review the current literature and critically discuss the differe...

Full description

Bibliographic Details
Main Authors:	Bahaa Abu-Raya, Marina Viñeta Paramo, Frederic Reicherz, Pascal Michel Lavoie
Format:	Article
Language:	English
Published:	Elsevier 2023-07-01
Series:	EClinicalMedicine
Subjects:	RSV Resurgence Waning immunity COVID-19 Co-infection
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537023002663

Similar Items

Respiratory syncytial virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada: a retrospective observational studyResearch in context
by: Marina Viñeta Paramo, et al.
Published: (2023-09-01)

Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre
by: Sara Manti, et al.
Published: (2022-11-01)

Pre-COVID-19-pandemic RSV epidemiology and clinical burden in pediatric primary care in Italy: a comparative analysis across two regions for the 2019/2020 season
by: Elisabetta Pandolfi, et al.
Published: (2024-04-01)

Determinants of RSV epidemiology following suppression through pandemic contact restrictions
by: Mihaly Koltai, et al.
Published: (2022-09-01)

Epidemiology and molecular characteristics of respiratory syncytial virus (RSV) among italian community-dwelling adults, 2021/22 season
by: Donatella Panatto, et al.
Published: (2023-03-01)

RSV disease in infants and young children: Can we see a brighter future?
by: Eugenio Baraldi, et al.
Published: (2022-11-01)

Preventing RSV Infection in Children: Current Passive Immunizations and Vaccine Development
by: Pius I. Babawale, et al.
Published: (2025-01-01)

Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
by: Mark H. Rozenbaum, et al.
Published: (2023-01-01)

The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
by: Gengxin Zhang, et al.
Published: (2024-10-01)

RSV Disease Threat and Innovative Prevention Methods in Health Protection: A Review
by: Paulina Dąbrowska, et al.
Published: (2024-02-01)

Susceptibility to Resurgent COVID-19 Outbreaks Following Vaccine Rollouts: A Modeling Study
by: Georgios Neofotistos, et al.
Published: (2022-10-01)

Respiratory Syncytial Virus (RSV) Hospitalizations in the Elderly in a Tertiary Care Hospital in Southern Italy as a Useful Proxy for Targeting Vaccine Preventive Strategies
by: Francesca Centrone, et al.
Published: (2024-05-01)

The new reporting obligation for Respiratory Syncytial Virus (RSV) in Germany – a critical view
by: Heudorf, Ursel, et al.
Published: (2024-04-01)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
by: Freek Cox, et al.
Published: (2023-03-01)

Influenza A Virus Inhibits RSV Infection via a Two-Wave Expression of IFIT Proteins
by: Yaron Drori, et al.
Published: (2020-10-01)

Psychometric evaluation of the respiratory syncytial virus infection, intensity and impact questionnaire (RSV-iiiQ) in adults
by: Valerie Williams, et al.
Published: (2024-02-01)

Pediatric RSV infection and respiratory coinfections: Is a link related to clinical severity? Single center retrospective study
by: Raffaele Falsaperla, et al.
Published: (2024-12-01)

The Importance of RSV Epidemiological Surveillance: A Multicenter Observational Study of RSV Infection during the COVID-19 Pandemic
by: Giulia Pruccoli, et al.
Published: (2023-01-01)

Prophylaxis protects infants with congenital heart disease from severe forms of RSV infection: an Italian observational retrospective study
by: Chiara Ratti, et al.
Published: (2023-01-01)

A multifaceted approach to RSV vaccination
by: Jorge C. G. Blanco, et al.
Published: (2018-07-01)

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
by: Harrison C. Bergeron, et al.
Published: (2022-10-01)

Evaluating the Effectiveness of Nirsevimab in Reducing Pediatric RSV Hospitalizations in Spain
by: Sara Jimeno Ruiz, et al.
Published: (2024-10-01)

New Look at RSV Infection: Tissue Clearing and 3D Imaging of the Entire Mouse Lung at Cellular Resolution
by: Maxence Frétaud, et al.
Published: (2021-01-01)

Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities
by: Jintanat Ananworanich, et al.
Published: (2021-08-01)

Infodemiology of RSV in Italy (2017–2022): An Alternative Option for the Surveillance of Incident Cases in Pediatric Age?
by: Matteo Riccò, et al.
Published: (2022-12-01)

Researchers combat resurgence of bed bug in behavioral studies and monitor trials
by: Vernard Lewis, et al.
Published: (2013-07-01)

The surge of RSV and other respiratory viruses among children during the second COVID-19 pandemic winter season
by: Angela Riepl, et al.
Published: (2023-02-01)

Immunity to RSV in Early Life
by: Laura eLambert, et al.
Published: (2014-09-01)

IFN-γ Attenuates Eosinophilic Inflammation but Is Not Essential for Protection against RSV-Enhanced Asthmatic Comorbidity in Adult Mice
by: Abenaya Muralidharan, et al.
Published: (2022-01-01)

Xuanfei Formula inhibited RSV infection by normalizing the SREBP2-mediated cholesterol synthesis process
by: Huan Qin, et al.
Published: (2024-05-01)

Evolving Epidemiology of Pediatric Respiratory Syncytial Virus (RSV) Cases Around COVID-19 Pandemic: Impact and Clinical Insights, Retrospective Cohort Study
by: Deema Gashgarey, et al.
Published: (2024-04-01)

Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options
by: Matteo Riccò, et al.
Published: (2024-11-01)

Immunogenicity, safety and reactogenicity of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 to 75 years: A comparison of phase 2b and phase 3 clinical trial material
by: Archana Jastorff, et al.
Published: (2024-12-01)

Editorial: How RSV outsmarts the host
by: Stephania A. Cormier, et al.
Published: (2024-12-01)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
by: Ariel Isaacs, et al.
Published: (2021-01-01)

Correlative outcomes of maternal immunization against RSV in cotton rats
by: Jorge C. G. Blanco, et al.
Published: (2022-12-01)

Recovery from Triple Infection with SARS-CoV-2, RSV and Influenza virus: A case report
by: Giacomo Guido, et al.
Published: (2023-07-01)

Prevention of Lower Respiratory Tract Diseases caused by RSV in Infants in Poland: A Review of Current Recommendations
by: Gabriela Zofia Mierzwa, et al.
Published: (2024-12-01)

Pre COVID-19 molecular epidemiology of respiratory syncytial virus (RSV) among children in Bangladesh
by: Mohammad Enayet Hossain, et al.
Published: (2022-10-01)

Case Report: ASCENIV use in three young children with immune abnormalities and acute respiratory failure secondary to RSV infection
by: Constance Bindernagel, et al.
Published: (2023-09-01)